NCT04485286View on ClinicalTrials.gov

Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury

PHASE2RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

July 19, 2020

Primary Completion Date

May 31, 2027

Study Completion Date

July 31, 2027

Conditions
Lung CancerRadiation FibrosisRadiation Induced Lung InjuryPancreas Cancer
Interventions
DRUG

[68Ga]CBP8

Up to 15 mCi of \[68Ga\]CBP8 will be administered to each subject. Each subject will undergo baseline imaging prior to radiation and again 3-6 months after radiation therapy.

Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Massachusetts General Hospital

OTHER